For biomedical researchers and biotechnology companies moving from discovery to manufacturing, a partnership with the Gates Biomanufacturing Facility (GBF) goes well beyond what the term “GMP facility” might indicate. GBF is an academic Good Manufacturing Practice (GMP) facility that collaborates effectively with our clients to efficiently translate new agents into ground breaking, first in human, Phase I clinical trials. With the patient top-of-mind, our employees come to work focused on getting your Advanced Therapy Medicinal Products or biologic manufactured to specification, every time.

For GBF, the saying, “from bench to bedside” is more than a slogan. It’s an apt description of its ability, as a uniquely positioned Phase 1 CDMO, to develop new science into preclinical batches that can quite literally be walked to trials performed at The University of Colorado Hospital or Children’s Hospital Colorado.